Gross Margin PressuresTransitory headwinds impacted F4Q gross margins, including the delay in clearance for the China treatment planning system, ongoing negative Fx impacts from the Japanese Yen, supplier quality issues, and lower revenue contribution from the higher-margin U.S. market.
Market WeaknessThe Americas region continued to show weakness in Q4 with product revenue down 50% YoY.
Regional ChallengesThe company faces challenges in the US and EIMEA regions, with revenue declines in these areas.